Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Medicine, Empagliflozin, Renal function, Internal medicine, Diuretic, and Linagliptin.
Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial
Empagliflozin Improves Kidney Outcomes in Patients With or Without Heart Failure
Neurovascular Response to Pressure in Patients With Diabetic Foot Ulcer
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized <scp>MARLINA</scp> ‐ <scp>T2D</scp> trial